Pharmaceutical Excipients Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Pharmaceutical Excipients Market: By Product (Inorganic Chemicals, Organic Chemicals, Petrochemicals), By Function (Fillers and Diluents, Coatings, Binders, Disintegrants, Flavouring Agents, Colorants), By Dosage Form (Tablets, Capsules, Liquids, Injections), By End User (Biotech Companies, Pharmaceutical Companies, Research Institutes) and Geography 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global pharmaceutical excipients market size is expected to reach USD 10.8 billion by 2027 from USD 6.9 billion in 2021, at a CAGR of 6.1% during the forecast period. Pharmaceutical excipients are combined with active pharmaceutical ingredients to produce the final dosage form of the drugs. The excipients provide bulkiness to formulation, facilitates absorption of the drug, provides stability and prevent from the drugs from denaturation. pharmaceutical excipients market are cost effective, stable, feasible for handling, and inert in the nature. The excipient is a material that has been tested for safety and is added to a medication delivery system. It is not an active pharmaceutical ingredient (API). The main functions of excipients are to protect, support, improve stability, bioavailability, patient acceptability, and aid in effectiveness. The market is made up of sales of pharmaceutical excipients and revenue earned by the company’s manufacturing of these excipients. The major advantages of using excipients are improving property of wetting, increase bulkiness of drug, provides stability, and improves the organoleptic properties of the drug. Excipients are used in a different medicinal products like capsules, tablets, oral liquids, inhalers, implants and injections among others. Factors such as patient compliance and ease in consumption forcing drug manufactures in developing a sustained release dosage formulations which contributes to the extension of shelf life of the oral drugs that adds to the high revenue anticipation of pharmaceutical excipients. However, lack of standard quality policies and regulations for excipients and safety evaluation is expected to hamper the growth of the market over the forecast period.


Pharmaceutical Excipients Market

MARKET SUMMARY
-
6.1% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 6.1%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Pharmaceutical Excipients Market Report

  • The report on global pharmaceutical excipients market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, form type and geography.
  • pharmaceutical excipients market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • This business expansions, new product launches, mergers & acquisitions and collaborations with educational universities are the key strategies adopted by most companies in the global pharmaceutical excipients market.
Major Key Players
  • Ashland Inc.(U.S.)
  • AkzoNobel (Netherlands)
  • The DOW Chemical Company (U.S.)
  • Archer Daniels Midland Company(U.S.)
  • Associated British Foods PLC (UK)
  • Colorcon, Inc.(U.S.)
Pharmaceutical Excipients Market

Drivers and Restrains

Global pharmaceutical excipients market is driven by growing demand for oral pharmaceuticals (solid) and development of novel therapeutics because of increase in pharmaceutical industries. The combination of nanotechnology and drug formulations in excipients led the development of nano-derived liposomes, vaccines, and nano coated tablets. The global pharmaceutical excipients market is expected to grow at a significant CAGR over the forecast period owing to increase in utilization of parenteral products, rise in the global burden of chronic & lifestyle diseases and increasing investments by the pharmaceutical industry on the development of biologics. Good manufacturing and distribution practices for for uniform excipients, spanning regions by international regulatory authorities is set to define the market landscape of the excipient industry over the forecast period.


North America got significant share

pharmaceutical excipients market

The global market of pharmaceutical excipients is segmented into 5 key regions, North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America followed Europe dominates in terms of the size of the excipients market globally. Emerging market like Asia-Pacific is expected to show lucrative growth opportunity owing to the availability of lower labour cost, skilled work force in and low cost of raw materials. Countries such as Brazil, India, and China are expected to be the major contributors to the growth of pharmaceutical excipients market owing to rising per capita income and most of the companies present in developed regions willing to establish manufacturing facilities in developing regions due to their low cost of manufacturing and processing.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

KEY FEATURES OF THE REPORT

  • The report provides granular level information about the market size, regional market share and forecast from 2017-2023
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Key

Notable Market Developments

Pharmaceutical Excipients Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

Some of the Key players operating in global pharmaceutical excipients market are Ashland Inc.(U.S.), AkzoNobel (Netherlands), The DOW Chemical Company (U.S.), Archer Daniels Midland Company(U.S.), Associated British Foods PLC (UK), Colorcon, Inc.(U.S.), BASF SE(Germany), Evonik Industries AG (Germany), Innophos Holdings Inc. (U.S.), J.M. Huber Corporation (U.S.), FMC Corporation (U.S.), Roquette Group (Nord-Pas de Calais), Croda International PLC (UK),Merck KGaA (U.S.) and Lubrizol Corporation (U.S.) to name a few.

 

Description

The global pharmaceutical excipients market size is expected to reach USD 10.8 billion by 2027 from USD 6.9 billion in 2021, at a CAGR of 6.1% during the forecast period. Pharmaceutical excipients are combined with active pharmaceutical ingredients to produce the final dosage form of the drugs. The excipients provide bulkiness to formulation, facilitates absorption of the drug, provides stability and prevent from the drugs from denaturation. pharmaceutical excipients market are cost effective, stable, feasible for handling, and inert in the nature. The excipient is a material that has been tested for safety and is added to a medication delivery system. It is not an active pharmaceutical ingredient (API). The main functions of excipients are to protect, support, improve stability, bioavailability, patient acceptability, and aid in effectiveness. The market is made up of sales of pharmaceutical excipients and revenue earned by the company’s manufacturing of these excipients. The major advantages of using excipients are improving property of wetting, increase bulkiness of drug, provides stability, and improves the organoleptic properties of the drug. Excipients are used in a different medicinal products like capsules, tablets, oral liquids, inhalers, implants and injections among others. Factors such as patient compliance and ease in consumption forcing drug manufactures in developing a sustained release dosage formulations which contributes to the extension of shelf life of the oral drugs that adds to the high revenue anticipation of pharmaceutical excipients. However, lack of standard quality policies and regulations for excipients and safety evaluation is expected to hamper the growth of the market over the forecast period.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX